Erlotinib versus vinorelbine plus cisplatin as adjuvant therapy in Chinese patients with stage IIIA EGFR mutation-positive non-small-cell lung cancer (EVAN): a randomised, open-label, phase 2 trial
| Autor: | Yue, Dongsheng, Xu, Shidong, Wang, Qun, Li, Xiaofei, Shen, Yi, Zhao, Heng, Chen, Chun, Mao, Weimin, Liu, Wei, Liu, Junfeng, Zhang, Lanjun, Ma, Haitao, Li, Qiang, Yang, Yue, Liu, Yongyu, Chen, Haiquan, Wang, Changli |
|---|---|
| Zdroj: | In The Lancet Respiratory Medicine November 2018 6(11):863-873 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|